[
  {
    "ts": null,
    "headline": "Pfizer (PFE) Stock Dips While Market Gains: Key Facts",
    "summary": "Pfizer (PFE) closed at $26.21 in the latest trading session, marking a -0.38% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=9ef5fe8955fa7e91ad4eb1843700354d3cda0328b635592710cad30e39935dc5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742420717,
      "headline": "Pfizer (PFE) Stock Dips While Market Gains: Key Facts",
      "id": 133325262,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) closed at $26.21 in the latest trading session, marking a -0.38% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=9ef5fe8955fa7e91ad4eb1843700354d3cda0328b635592710cad30e39935dc5"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer (NYSE:PFE) To Divest Entire 7 Percent Stake In Haleon Through Share Offering",
    "summary": "Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment strategy that prominently featured an accelerated book building process aimed at institutional investors. This development comes amidst various challenges and opportunities faced by the company, including investor activism with shareholder proposals addressing corporate governance concerns and positive clinical trial results for vepdegestrant in partnership with Arvinas,...",
    "url": "https://finnhub.io/api/news?id=791d339f3eb33aafa517683973211a475428ae303f9a2dc792ed32d68eb34c26",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742405332,
      "headline": "Pfizer (NYSE:PFE) To Divest Entire 7 Percent Stake In Haleon Through Share Offering",
      "id": 133325263,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment strategy that prominently featured an accelerated book building process aimed at institutional investors. This development comes amidst various challenges and opportunities faced by the company, including investor activism with shareholder proposals addressing corporate governance concerns and positive clinical trial results for vepdegestrant in partnership with Arvinas,...",
      "url": "https://finnhub.io/api/news?id=791d339f3eb33aafa517683973211a475428ae303f9a2dc792ed32d68eb34c26"
    }
  },
  {
    "ts": null,
    "headline": "Immunovant: TED Data Sets Stage For Batoclimab Regulatory Filings Going Forward",
    "summary": "Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data expected in 2025. Click for my IMVT update.",
    "url": "https://finnhub.io/api/news?id=ede01e2890b795153db1e4b34765bfb8f05fc93cbd0b22831c1421d0fd7e788d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742404070,
      "headline": "Immunovant: TED Data Sets Stage For Batoclimab Regulatory Filings Going Forward",
      "id": 133262430,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2196323969/image_2196323969.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Immunovant, Inc. had positive results for batoclimab in trials for Myasthenia Gravis & CIDP; Thyroid Eye Disease data expected in 2025. Click for my IMVT update.",
      "url": "https://finnhub.io/api/news?id=ede01e2890b795153db1e4b34765bfb8f05fc93cbd0b22831c1421d0fd7e788d"
    }
  },
  {
    "ts": null,
    "headline": "Top Midday Stories: EC Notifies Alphabet of DMA Noncompliance, Adopts Requirements for Apple; Boeing Expects Less Q1 Cash Outflow",
    "summary": "All three major US stock indexes were up in late-morning trading as investors await the Federal Rese",
    "url": "https://finnhub.io/api/news?id=877c774e34a274f34164096989e8ee8153230f25b4ff1859c95b81f7b15720fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742399433,
      "headline": "Top Midday Stories: EC Notifies Alphabet of DMA Noncompliance, Adopts Requirements for Apple; Boeing Expects Less Q1 Cash Outflow",
      "id": 133325264,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "All three major US stock indexes were up in late-morning trading as investors await the Federal Rese",
      "url": "https://finnhub.io/api/news?id=877c774e34a274f34164096989e8ee8153230f25b4ff1859c95b81f7b15720fa"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE): The Most Undervalued Biotech Stock to Invest In",
    "summary": "We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other most undervalued biotech stocks to invest in. Trump’s Tariffs and the Pharma Sector On February 21, Jared Holz, Mizuho Securities America’s […]",
    "url": "https://finnhub.io/api/news?id=0ba6b4d2c77340a6b70c400469624b4e6fe2f54c69ae6a80e13b83a2114b42d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742395752,
      "headline": "Pfizer Inc. (PFE): The Most Undervalued Biotech Stock to Invest In",
      "id": 133325265,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other most undervalued biotech stocks to invest in. Trump’s Tariffs and the Pharma Sector On February 21, Jared Holz, Mizuho Securities America’s […]",
      "url": "https://finnhub.io/api/news?id=0ba6b4d2c77340a6b70c400469624b4e6fe2f54c69ae6a80e13b83a2114b42d7"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant",
    "summary": "Pfizer offloads its 7.3% Haleon stake, raising $3.24B as BlackRock emerges as the new top shareholder",
    "url": "https://finnhub.io/api/news?id=7c606b939f29a8412a782de3bac4e672ba8444c9c8b51bca27e6684d042b9ac8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742391559,
      "headline": "Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant",
      "id": 133325266,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer offloads its 7.3% Haleon stake, raising $3.24B as BlackRock emerges as the new top shareholder",
      "url": "https://finnhub.io/api/news?id=7c606b939f29a8412a782de3bac4e672ba8444c9c8b51bca27e6684d042b9ac8"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding",
    "summary": "Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding",
    "url": "https://finnhub.io/api/news?id=de3a6428b10942158675f3828c0448e24892fa22fe2e6f17d59b6b26223320aa",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742378400,
      "headline": "Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding",
      "id": 133242802,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Gilead Stock Falls on Report Trump Administration Wants to Cut HIV-Prevention Funding",
      "url": "https://finnhub.io/api/news?id=de3a6428b10942158675f3828c0448e24892fa22fe2e6f17d59b6b26223320aa"
    }
  },
  {
    "ts": null,
    "headline": "10 Undervalued Dividend Growth Stocks: March 2025",
    "summary": "Read here for an analysis of top 10 undervalued dividend growth stocks yielding 4%+ with expert quality assessments and valuation insights.",
    "url": "https://finnhub.io/api/news?id=7d3209c952424595ff3eca0b0289d0228cfe59be6469dd1c4632b2e1a4fc4cec",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742374800,
      "headline": "10 Undervalued Dividend Growth Stocks: March 2025",
      "id": 133240018,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/181131486/image_181131486.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Read here for an analysis of top 10 undervalued dividend growth stocks yielding 4%+ with expert quality assessments and valuation insights.",
      "url": "https://finnhub.io/api/news?id=7d3209c952424595ff3eca0b0289d0228cfe59be6469dd1c4632b2e1a4fc4cec"
    }
  },
  {
    "ts": null,
    "headline": "March's 5 Dividend Growth Stocks With Yields Up To 7.3%",
    "summary": "Dividend growth can be an important tool for income-focused investors to help combat the negative impact that inflation has on one's buying power. Read more here.",
    "url": "https://finnhub.io/api/news?id=732852c9154ec6a81e92404ffdce365b998ff2df6f22e7af19a0a7ac9236dac5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742369129,
      "headline": "March's 5 Dividend Growth Stocks With Yields Up To 7.3%",
      "id": 133239448,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2176547480/image_2176547480.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Dividend growth can be an important tool for income-focused investors to help combat the negative impact that inflation has on one's buying power. Read more here.",
      "url": "https://finnhub.io/api/news?id=732852c9154ec6a81e92404ffdce365b998ff2df6f22e7af19a0a7ac9236dac5"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer completes GBP2.5 billion sale of last stake in Haleon",
    "summary": "Pfizer Inc disposed of its entire residual stake in Haleon PLC, selling 662 million shares in the consumer health firm through a placing with institutional investments and a share buyback by...",
    "url": "https://finnhub.io/api/news?id=d34a83fc39eae30c959d89e8fe2d2891cab2f22ff3da528bc9020e4ef0cfb892",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742363297,
      "headline": "Pfizer completes GBP2.5 billion sale of last stake in Haleon",
      "id": 133238755,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Pfizer Inc disposed of its entire residual stake in Haleon PLC, selling 662 million shares in the consumer health firm through a placing with institutional investments and a share buyback by...",
      "url": "https://finnhub.io/api/news?id=d34a83fc39eae30c959d89e8fe2d2891cab2f22ff3da528bc9020e4ef0cfb892"
    }
  },
  {
    "ts": null,
    "headline": "Deals of the day-Mergers and acquisitions",
    "summary": "The following bids, mergers,acquisitions and disposals were reported by 0930 GMT onWednesday: ** British asset manager Intermediate Capital Groupplans to sell PSB Academy, one of...",
    "url": "https://finnhub.io/api/news?id=5f6a057f85b0e709da68f6c08aed716d88b2de6d480985cdc130437cec901658",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742362721,
      "headline": "Deals of the day-Mergers and acquisitions",
      "id": 133238714,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "The following bids, mergers,acquisitions and disposals were reported by 0930 GMT onWednesday: ** British asset manager Intermediate Capital Groupplans to sell PSB Academy, one of...",
      "url": "https://finnhub.io/api/news?id=5f6a057f85b0e709da68f6c08aed716d88b2de6d480985cdc130437cec901658"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer sells entire Haleon stake for $3.24 billion",
    "summary": "Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for the deal said...",
    "url": "https://finnhub.io/api/news?id=fa000960a236e979c95d5be55f05c05ef65efdbf49b3ec7189eb81aec31a2c50",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742355418,
      "headline": "Pfizer sells entire Haleon stake for $3.24 billion",
      "id": 133237943,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for the deal said...",
      "url": "https://finnhub.io/api/news?id=fa000960a236e979c95d5be55f05c05ef65efdbf49b3ec7189eb81aec31a2c50"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion",
    "summary": "By Ian Walker Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds . Pfizer sold 618 million shares for 385 pence each....",
    "url": "https://finnhub.io/api/news?id=dba903145cd86522a16058dc732ed474960887927736733d0ba873989eddbad2",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742355331,
      "headline": "Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion",
      "id": 133237917,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "By Ian Walker Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds . Pfizer sold 618 million shares for 385 pence each....",
      "url": "https://finnhub.io/api/news?id=dba903145cd86522a16058dc732ed474960887927736733d0ba873989eddbad2"
    }
  },
  {
    "ts": null,
    "headline": "Citigroup Says Pfizer Raises About £2.4 Billion In Haleon Stake Sale",
    "summary": "Citigroup Global Markets Limited: * CITIGROUP GLOBAL MARKET HALEON PLC - PRICING OF OFFERINGINHALEON PLC BY PFIZER INC. * CITIGROUP- PFIZER SELLS 618 MILLION HALEON...",
    "url": "https://finnhub.io/api/news?id=a5d7109ae5db9511231fa4396b97618597dab5a478aae2e56f0496af0e050d1e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742354348,
      "headline": "Citigroup Says Pfizer Raises About £2.4 Billion In Haleon Stake Sale",
      "id": 133237840,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "Citigroup Global Markets Limited: * CITIGROUP GLOBAL MARKET HALEON PLC - PRICING OF OFFERINGINHALEON PLC BY PFIZER INC. * CITIGROUP- PFIZER SELLS 618 MILLION HALEON...",
      "url": "https://finnhub.io/api/news?id=a5d7109ae5db9511231fa4396b97618597dab5a478aae2e56f0496af0e050d1e"
    }
  }
]